House already passed legislation to amend Sec. 13(b) of FTC regulations and make explicit its authority to obtain injunctive and equitable relief in court, but differences in Democrat and Republican commission appointees' views on the authority was a key topic of discussion during a recent Energy and Commerce hearing.

“Amazon has taken some action when alerted by the FDA about sales” of violative supplements, but FDA "found that other such products continue to be offered for sale” by the firm through its Fulfillment by Amazon service, according to untitled letter.

FDA debars Matthew Hebert, USPlabs co-owner “with primarily responsibilities over product packaging design,” for five years from importing dietary ingredients or other articles of food.

Mary Agrotechnologies CEO Frank Qin says he is “not too concerned” about China's recent  CBD cosmetics ban, despite his company's plans to build a 150,000 square-foot cultivation and extraction plant in Yunnan, with the aim of supplying the domestic CBD market and exporting overseas.

House already passed legislation to amend Sec. 13(b) of FTC regulations and make explicit its authority to obtain injunctive and equitable relief in court, but differences in Democrat and Republican commission appointees' views on the authority was a key topic of discussion during a recent Energy and Commerce hearing.

Including fees was key to Congress passing FSMA more than a decade ago and FDA had industry support asking for fees. But FDA calculations for FY2022 user fees act continue to add up to not collecting fees for facility re-inspections and recall enforcement.